Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Molecular Weight Conversions for Cross-Study Comparisons

Some research protocols specify doses in molar units (micromolar, μM) rather than mass units (μg or mg), particularly when comparing thymosin alpha-1 to other immune-modulating peptides with different molecular weights. Converting between mass concentration an

This comparison does not assign a generated winner or score.

  • Some research protocols specify doses in molar units (micromolar, μM) rather than mass units (μg or mg), particularly when comparing thymosin alpha-1 to other immune-modulating peptides with different molecular weights. Converting between mass concentration and molar concentration requires the peptide's molecular weight (3,108.3 Da for thymosin alpha-1) and the relationship: Molarity (M) = [mass concentration (g/L)] ÷ [molecular weight (g/mol)].
  • Example: a 4.9 mg/mL solution expressed in grams per liter is 4.9 g/L. To convert to molarity: 4.9 g/L ÷ 3,108.3 g/mol = 0.00158 mol/L = 1.58 millimolar (mM) = 1,580 micromolar (μM). Now, if a protocol specifies a 500 μM dose, you can calculate the required mass: 500 μM = 0.0005 mol/L, which equals 0.0005 × 3,108.3 = 1.554 g/L = 1.554 mg/mL. If your stock solution is 4.9 mg/mL, you'd need to dilute it by a factor of 4.9 ÷ 1.554 = 3.15× to reach 500 μM working concentration.
  • Molar conversions matter most in multi-peptide studies where equimolar dosing allows direct mechanistic comparison. Thymosin alpha-1 (3,108.3 Da) and thymosin beta-4 (4,963 Da) both modulate immune function, but a 1mg dose of each represents different molar quantities. 0.322 micromoles for alpha-1 vs 0.201 micromoles for beta-4. Equimolar dosing (e.g., 10 μM of each) requires calculating the mass needed to reach that molarity for each peptide individually, which depends on knowing molecular weight precisely.
  • Calculating molar concentrations is where molecular weight errors cascade most visibly. If you mistakenly use thymosin beta-4's molecular weight (4,963 Da) for thymosin alpha-1 calculations, your calculated molarity will be 37% lower than actual. A 1,000 μM solution calculated with the wrong MW would actually be 1,596 μM, shifting every downstream dose and potentially invalidating cross-study comparisons. Real Peptides provides molecular weight confirmation on every COA to prevent this exact error.
  • A final note on concentration: once you've calculated it correctly, stability becomes the variable that determines whether your concentration remains accurate across the vial's usage period. Reconstituted thymosin alpha-1 in bacteriostatic water maintains 95%+ potency for 28 days when stored at 2–8°C, but each freeze-thaw cycle degrades the peptide by 3–8%. If your protocol requires long-term storage, aliquot the reconstituted solution into single-use vials immediately after mixing. This preserves your calculated concentration by preventing repeated temperature cycling that breaks down the peptide's tertiary structure and reduces bioactivity below your intended dose.
More references

Related material